Daniel G. Mariam

Array ( [id] => 3842910 [patent_doc_number] => 05766597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Malaria recombinant poxviruses' [patent_app_type] => 1 [patent_app_number] => 8/257073 [patent_app_country] => US [patent_app_date] => 1994-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 12 [patent_no_of_words] => 45816 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766597.pdf [firstpage_image] =>[orig_patent_app_number] => 257073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3970619 [patent_doc_number] => 05916563 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Parvovirus protein presenting capsids' [patent_app_type] => 1 [patent_app_number] => 8/253539 [patent_app_country] => US [patent_app_date] => 1994-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 39 [patent_no_of_words] => 7291 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916563.pdf [firstpage_image] =>[orig_patent_app_number] => 253539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3514192 [patent_doc_number] => 05505947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'Attenuating mutations in Venezuelan Equine Encephalitis virus' [patent_app_type] => 1 [patent_app_number] => 8/250445 [patent_app_country] => US [patent_app_date] => 1994-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 4248 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/505/05505947.pdf [firstpage_image] =>[orig_patent_app_number] => 250445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3558330 [patent_doc_number] => 05525342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Reovirus strain 2177 and vaccine containing same' [patent_app_type] => 1 [patent_app_number] => 8/247174 [patent_app_country] => US [patent_app_date] => 1994-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7876 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525342.pdf [firstpage_image] =>[orig_patent_app_number] => 247174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580879 [patent_doc_number] => 05580772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Association between a novel human intracisternal A-type retroviral particle-type II (HIAP-II) and idiopathic CD4+ T-lymphocytopenia (ICL)' [patent_app_type] => 1 [patent_app_number] => 8/245385 [patent_app_country] => US [patent_app_date] => 1994-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5737 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580772.pdf [firstpage_image] =>[orig_patent_app_number] => 245385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692898 [patent_doc_number] => 05595740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens' [patent_app_type] => 1 [patent_app_number] => 8/242932 [patent_app_country] => US [patent_app_date] => 1994-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 10718 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595740.pdf [firstpage_image] =>[orig_patent_app_number] => 242932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625555 [patent_doc_number] => 05686239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Hepatitis E virus peptides and methods' [patent_app_type] => 1 [patent_app_number] => 8/240049 [patent_app_country] => US [patent_app_date] => 1994-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 4 [patent_no_of_words] => 13397 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686239.pdf [firstpage_image] =>[orig_patent_app_number] => 240049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619060 [patent_doc_number] => 05601826 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Peptide which produces protective immunity against tetanus' [patent_app_type] => 1 [patent_app_number] => 8/231437 [patent_app_country] => US [patent_app_date] => 1994-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3975 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601826.pdf [firstpage_image] =>[orig_patent_app_number] => 231437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53588 [patent_doc_number] => 07767449 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-03 [patent_title] => 'Methods using modified vaccinia virus' [patent_app_type] => utility [patent_app_number] => 08/228926 [patent_app_country] => US [patent_app_date] => 1994-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 50 [patent_no_of_words] => 33232 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767449.pdf [firstpage_image] =>[orig_patent_app_number] => 08228926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835101 [patent_doc_number] => 05744140 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Flavivirus recombinant poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/224391 [patent_app_country] => US [patent_app_date] => 1994-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 28358 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744140.pdf [firstpage_image] =>[orig_patent_app_number] => 224391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3765452 [patent_doc_number] => 05756102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants' [patent_app_type] => 1 [patent_app_number] => 8/224657 [patent_app_country] => US [patent_app_date] => 1994-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 51 [patent_no_of_words] => 41138 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756102.pdf [firstpage_image] =>[orig_patent_app_number] => 224657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790477 [patent_doc_number] => 05780266 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Feline infectious peritonitis virus diagnostic tools' [patent_app_type] => 1 [patent_app_number] => 8/220401 [patent_app_country] => US [patent_app_date] => 1994-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 11631 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780266.pdf [firstpage_image] =>[orig_patent_app_number] => 220401 [rel_patent_id] =>[rel_patent_doc_number] =>)